Have £2,000? Here are 2 essential UK growth shares I’d buy and hold for retirement

Looking to grow your money for retirement? Paul Summers thinks these two small-cap stocks have the potential to reward investors handsomely over the long term.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Buying stocks for retirement is easy. It’s having the patience to hold on to them that a lot of people find difficult.

One way around this is to build stakes in companies providing products or services that are deemed ‘essential’ to daily life. Since earnings should be relatively constant (or rising), there’s less incentive to check out early. 

Here are a couple of small-cap stocks with great growth prospects I think fit this strategy well. 

Eyes on retirement

New-stock-on-the-block Inspecs (LSE: SPEC) designs, manufactures and distributes eyewear frames to global retail chains. It may not quicken the pulse like a glitzy tech share but, for me, that’s part of the appeal. Some of the best investments are those that rarely make headlines.

Unsurprisingly, Inspecs was doing rather well before arriving on the market in February. In 2019, group revenue rose 6.9% to $61.25m and pre-tax profit more than doubled to $7.35m.

Of course, all this was pre-coronavirus. Like most businesses, the pandemic has motivated the small-cap to reduce costs and save cash where it can.  

Looking further ahead, however, the investment case becomes compelling. As CEO Robin Totterman stated in May: “The structural growth drivers in the $131 billion global eyewear market remain unchanged.” Moreover, the number of people requiring vision correction looks likely to increase as we learn more about the damage done from staring at computer screens and mobile phones for too long. 

It may be early days, but shares have done very well given what 2020 has thrown at investors so far. Had you bought in early April, you’d be sitting on a near-60% gain by now. This leaves the business trading at 14 times FY21 earnings. Considering the aforementioned growth prospects, that looks pretty reasonable.

The only thing I’d watch out for with Inspecs is the buy/sell spread. The larger this is, the more you’ll need the shares to rise just to get back to break-even. 

Long-term winner

If there was one lockdown trend that stood out for me, it was the huge demand for pets. This should be great news for leading veterinary service provider and online pharmacy operator CVS Group (LSE: CVSG) once the coronavirus crisis subsides. All those new, pampered family members will need regular care for years to come.

This isn’t to say CVS hasn’t been impacted by the pandemic. During lockdown, vets were restricted to undertaking only emergency work in their practices, leading to a “significant reduction” in revenue.

In response, the company temporality shut half of its small animal practices and placed half of its employees on furlough. Thankfully, a recovery in revenues to “pre-Covid-19 levels” since has led management to predict that full-year revenue will now come in “comfortably ahead of the prior year.”

Changing hands for 22 times forecast FY21 earnings, CVS is unlikely to appeal to committed value investors. Some may also be concerned by the company’s reluctance to comment on its earnings outlook or pay a final dividend.

For me, however, all this seems very prudent. With more local lockdowns looming, the move to permanently close 33 mostly-small branches, a proportion of which were loss-making, also makes sense. 

The short-term outlook may be foggy but I think CVS is a great pick for those building their wealth for retirement.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »